Researchsubject-example-crossover-placebo-to-drug

R5 Final QA

This page is part of the FHIR Specification (v5.0.0-draft-final: Final QA Preview for R5 - see ballot notes). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions

Example ResearchSubject/example-crossover-placebo-to-drug (Narrative)

Biomedical Research and Regulation Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: Device, Patient

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ResearchSubject.

Generated Narrative: ResearchSubject

Resource ResearchSubject "example-crossover-placebo-to-drug"

identifier: id: ecsr45

status: active

progress
type: Enrollment status (ResearchSubjectStateType#Enrollment)

progress
type: Enrollment status (ResearchSubjectStateType#Enrollment)
subjectState: On-study (ResearchSubjectState#on-study)
reason: Informed consent signed ([not stated]#informedConsentSigned)
startDate: 2022-06-10

period: 2022-06-10 --> (ongoing)

study: example-ctgov-study-record

subject: cfsb1676546565857

assignedComparisonGroup: placebo

actualComparisonGroup: ap303

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.